Welche Hormontherapie bei fortgeschrittenem Mammakarzinom des Mannes?
Autor: | Per Eystein Lønning, Wiedemann G, S. Kvinnsland, Lundgren S |
---|---|
Rok vydání: | 2008 |
Předmět: |
Oncology
medicine.medical_specialty biology business.industry medicine.medical_treatment General Medicine medicine.disease Breast cancer Internal medicine Megestrol acetate Carcinoma medicine biology.protein Medroxyprogesterone acetate Hormone therapy Aromatase business Tamoxifen Aminoglutethimide medicine.drug |
Zdroj: | DMW - Deutsche Medizinische Wochenschrift. 113:1358-1361 |
ISSN: | 1439-4413 0012-0472 |
Popis: | A 76-year-old man with advanced carcinoma of the breast who had not been orchiectomized underwent sequential hormonal treatment. The tumour progressed during monotherapy with dexamethasone. Objective regression of the tumour followed sequential administration of tamoxifen (twice) and the two aromatase inhibitors, aminoglutethimide and testololactone. In addition, his condition remained stable on two progestogens in high doses, medroxyprogesterone acetate and megestrol acetate. |
Databáze: | OpenAIRE |
Externí odkaz: |